GHTM

Global Health and Tropical Medicine

  • GHTM
    • About GHTM
    • Governance
    • Impact
    • Members
      • Population health, policies and services
        • PPS PhD members
        • PPS non PhD members
      • TB, HIV and opportunistic diseases and pathogens
        • THOP PhD members
        • THOP non PhD members
      • Vector-borne diseases
        • VBD PhD members
        • VBD non PhD members
      • Individual Health Care
        • IHC PhD members
        • IHC non PhD members
      • Tech & Admin support
    • Scientific Advisory Board
  • Research
    • Cross-cutting issues
      • Global Pathogen Dispersion and Population Mobility
      • Drug Discovery and Drug Resistance
      • Diagnostics
      • Public Health Information
      • Fair Research Partnerships
    • Research Groups
      • PPS – Population health, policies and services
      • THOP – TB, HIV and opportunistic diseases and pathogens
      • VBD – Vector borne diseases
      • IHC – Individual health care
    • Research in numbers
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
    • Projects
      • Ongoing Projects
      • Completed Projects
  • Outreach
    • Events
    • News
    • Policy Support & Community Outreach
  • Publications
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
  • Capacity Building
    • Education
      • Master Theses
      • PhD Theses
    • International
  • Infrastructures
  • Networks & Partnerships
  • Reports
    • GHTM
    • Scientific Advisory Board
    • FCT
Home / Publications / The Role of Reservoirs: Canine Leishmaniasis

The Role of Reservoirs: Canine Leishmaniasis

  • Authors: Campino L, Maia C
  • Publication Year: 2018
  • Journal: Drug Resistance in Leishmania Parasites
  • Link: https://link.springer.com/chapter/10.1007/978-3-319-74186-4_3

Canine leishmaniasis caused by Leishmania (Leishmania) infantum species (syn. L. (L.) chagasi species in Latin America), which is transmitted by the bite of phlebotomine sand flies, is endemic and affects millions of dogs in Asia, Europe, North Africa, and South America and is considered as an emergent disease in North America. Domestic dogs (Canis familiaris) are the major hosts for these parasites and the main reservoir host for human infection.

Recent years have seen important advances on the epidemiology, pathology, and canine genetic factors linked with animal resistance or susceptibility to leishmaniasis. Despite the lack of pathognomonic manifestations, infection by Leishmania can be suspected if a combination of clinical signs is present, namely, lymphadenomegaly, cutaneous alterations, loss of body weight, ocular disturbs, epistaxis, onychogryphosis, and lameness. However, the definitive diagnosis of canine leishmaniasis is complex since not all infected animals develop signs of disease. This fact cannot be ignored since asymptomatic (without clinical signs) dogs are infectious to phlebotomine vectors, although at a lower risk than symptomatic (with clinical signs) dogs. The fact that dogs never achieve parasitological cure together with the widespread use of the available anti-Leishmania drugs for both canine and human treatment certainly contributes to the spread of drug-resistant parasites with the natural consequences for the clinical outcome of the disease.

Early detection of infection and close surveillance or treatment of infected animals together with the development of effective molecules for therapy (ideally different from the ones used for humans) and, more importantly, for immunoprophylaxis are essential to control the dissemination of the disease among other dogs, being also a crucial element for the control of human zoonotic leishmaniasis.

This chapter reviews the role of dogs as reservoir hosts of L. (L.) infantum and as accidental hosts of other Leishmania species, as well as the role of other mammals as potential reservoir hosts of parasites belonging to the L. (L.) donovani complex. The potential generation and spread of drug resistance by the use of the same compounds in both canine and human hosts are also discussed.

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to print (Opens in new window) Print

About GHTM

GHTM is a R&D Unit that brings together researchers with a track record in Tropical Medicine and International & Global Health. It aims at strengthening Portugal's role as a leading partner in the development and implementation of a global health research agenda. Our evidence-based interventions contribute to the promotion of equity in health and to improve the health of populations.

Contacts

Rua da Junqueira, 100
1349-008 Lisboa
Portugal

+351 213 652 600

  • E-mail
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Map

  • Events
  • Research Groups
  • Cross-cutting issues
© Copyright 2025 IHMT-UNL All Rights Reserved.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    UIDB/04413/2020
    UIDP/04413/2020

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok